Syros Pharmaceuticals Inc.

NASDAQ:SYRS  
5.20
-0.33 (-5.97%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)321.61M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.75 Million
Adjusted EPS-$0.44
See more estimates
10-Day MA$5.81
50-Day MA$7.39
200-Day MA$9.67
See more pivots

Syros Pharmaceuticals Inc. Stock, NASDAQ:SYRS

35 CambridgePark Drive, 4th floor, Cambridge, Massachusetts 02140
United States of America
Phone: +1.617.744.1340
Number of Employees: 103

Description

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.